Target intelligence / Profile preview

ABR antisense RNA 1 (ABR-AS1)

Target: ABR-AS1
Molecular classification: Long non-coding RNA (lncRNA), Antisense RNA

Overview

ABR antisense RNA 1 (ABR-AS1) is a non-protein-coding RNA gene, transcribed from the ABR gene locus in the antisense direction[4]. Like other antisense lncRNAs, it may play regulatory roles in gene expression, possibly by modulating expression of the ABR gene, but its specific biological function, mechanisms, and clinical relevance have not been characterized in the literature or major gene/protein databases. There is no evidence that ABR-AS1 functions as a receptor, enzyme, or other canonical drug target.

Mechanism of action

Not established. Antisense RNAs generally act via RNA-RNA interaction to regulate sense gene transcription or mRNA stability[1].

Beyond the preview

Go deeper on ABR antisense RNA 1 (ABR-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ABR antisense RNA 1 (ABR-AS1).

Explore the full profile